Patents Assigned to MediGene AG Gesellschaft fur Molekularbiologische Kardiologie und Onkologie
  • OxiranEcarboxylic acids for the treatment of diabetes
    Patent number: 6479676
    Abstract: The invention relates to novel arylalkyl- or aryloxyalkyl-substituted oxiranecarboxylic acids of the general formula I in which Ar, R3, Y and n are as defined in the description, and also to medicaments comprising them and to their use for the treatment and prophylaxis of the disorders mentioned in claim 4 which are caused by disturbances of glucose and/or lipid metabolism, such as, for example, diabetes type 2 and other insulin-resistant conditions.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: November 12, 2002
    Assignee: MediGene AG Gesellschaft fur Molekularbiologische Kardiologie und Onkologie
    Inventor: Horst P. O. Wolf